iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
Rhea-AI Summary
iRhythm Technologies, a digital health care company specializing in disease detection, prevention, and prediction solutions, has announced its participation in the upcoming Bank of America Securities 2025 Health Care Conference.
The company's management team is set to deliver their presentation on Tuesday, May 13, 2025, at 3:40 p.m. Pacific Time (6:40 p.m. Eastern Time). Investors and interested parties can access both the live presentation and its archived version through the "Events & Presentations" section on iRhythm's investor website at investors.irhythmtech.com.
Positive
- Company's presence at a major healthcare investment conference indicates strong institutional investor interest
- Management's direct participation in presenting company updates shows transparency and leadership engagement
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, IRTC gained 0.23%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities 2025 Health Care Conference.
iRhythm’s management is scheduled to present on Tuesday, May 13, 2025, 3:40 p.m. Pacific Time/6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
irhythm@highwirepr.com